
A judge blocked the FDA’s plan to regulate LDTs. What now?
The Food and Drug Administration’s attempt to increase regulatory scrutiny over laboratory developed tests appears to be dead, much to the relief of clinical labs. The FDA is unlikely to appeal the March 31 federal court order that set aside a final rule …